AI Article Synopsis
- After a heart attack (myocardial infarction), patients are more likely to develop heart failure, especially those with left ventricular systolic dysfunction.
- Clinical trials have shown that using neuro-hormonal inhibitors can significantly enhance survival rates and lower the chances of further heart issues.
- The article reviews existing drug treatments for patients following a heart attack, focusing on those with or without complications like heart failure.
Article Abstract
After myocardial infarction (MI), patients are at a greater risk of heart failure. Post-MI patients with left ventricular systolic dysfunction have a higher risk of mortality or morbidity. Strong and compelling data from randomized trials have demonstrated that drug therapies intended for preventing post-MI remodeling with neuro-hormonal inhibitors can considerably improve short- and long-term outcomes, including death, reinfarction, and worsening heart failure. This article aims at summarizing clinical data on established pharmacological therapies in treating post-MI patients with or without left ventricular systolic dysfunction (LVSD), and with or without signs and symptoms of heart failure.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC9264286 | PMC |
| http://dx.doi.org/10.7759/cureus.25745 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!